This suggests that the effect attributed to the polymorphism on lipid levels may have been caused by obesity or dyslipidaemia, rather than the polymorphism itself, as these effects were not present in the healthy control group, indicating that the impact of MTHFR polymorphisms on lipid levels also depends on the health status of the population studied. The gene discussed is MTHFR; the disease is obesity disorder.